GNH USA

Europe — EMA

Morniflu (Morniflumate)

GNH USA supplies Morniflu (Morniflumate), a pharmaceutical agent for various therapeutic uses. Request a quote for global supply.

Morniflumate

Request sourcing

1
Pack/s

What is Morniflumate?

Morniflumate, the active ingredient in Morniflu, is a pharmaceutical compound presented as an oral formulation for oral administration. It is employed in the management of inflammatory and musculoskeletal conditions, although detailed therapeutic classifications are not publicly disclosed.

GNH USA supplies Morniflu as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable sourcing for healthcare providers across multiple markets, and offering comprehensive regulatory support for import and distribution globally.

What is Morniflumate used for?

Morniflu (morniflumate) is reported to be used in the management of inflammatory and musculoskeletal disorders.

- Rheumatoid arthritis: may help reduce joint inflammation and pain - Osteoarthritis: may provide symptomatic relief of joint discomfort - Ankylosing spondylitis: may assist in controlling spinal inflammation

What are the side effects of Morniflumate?

Adverse reactions may occur with oral morniflumate therapy.

Common Side Effects: - Gastrointestinal upset: nausea, dyspepsia, or abdominal discomfort - Headache: mild to moderate intensity - Dizziness: transient episodes of light‑headedness - Skin rash: mild erythema or pruritus - Elevated liver enzymes: mild, asymptomatic increase - Fluid retention: mild peripheral edema

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding: potentially life‑threatening - Severe allergic reaction: anaphylaxis, angioedema, or Stevens‑Johnson syndrome - Hepatic injury: hepatitis or liver failure - Renal impairment: acute kidney injury or worsening chronic kidney disease - Cardiovascular events: increased risk of myocardial infarction or stroke - Hematologic abnormalities: thrombocytopenia or neutropenia

What precautions apply to Morniflumate?

When prescribing or dispensing Morniflu, consider the following safety measures.

- Assess renal function: evaluate baseline kidney parameters before therapy - Monitor hepatic enzymes: check liver function periodically during treatment - Avoid in patients with peptic ulcer disease: increased risk of gastrointestinal bleeding - Use caution with anticoagulants: heightened bleeding potential when combined - Avoid in known hypersensitivity to NSAIDs: risk of severe allergic reactions - Store at ambient temperature: keep in original container, protect from moisture

What does Morniflumate interact with?

Morniflu may interact with several drug classes; careful assessment is required.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of serious bleeding - Selective serotonin reuptake inhibitors (SSRIs): heightened gastrointestinal bleed risk - Other NSAIDs or COX‑2 inhibitors: additive gastrointestinal toxicity

Moderate Interactions (Monitor Closely): - Diuretics: possible reduction in renal function - ACE inhibitors or ARBs: may decrease renal perfusion, especially in volume‑depleted patients - Lithium: potential increase in serum lithium concentrations

Frequently asked questions

What is Morniflu used for?+
Morniflu contains morniflumate, a non‑steroidal anti‑inflammatory drug used to manage pain and inflammation associated with conditions such as rheumatoid arthritis, osteoarthritis and ankylosing spondylitis. The specific therapeutic indication is determined by the prescribing clinician based on patient needs.
How does Morniflumate work?+
Morniflumate exerts its effect by reversibly inhibiting cyclooxygenase‑1 and cyclooxygenase‑2 enzymes, which are key in the conversion of arachidonic acid to prostaglandins. By reducing prostaglandin synthesis, it diminishes inflammation, pain, and fever associated with musculoskeletal disorders.
What is the usual dose of Morniflu?+
The dosage of Morniflu is individualized; the prescribing healthcare professional determines the appropriate strength, frequency, and duration based on the patient’s condition, age, renal and hepatic function, and concomitant medications. Patients should follow the prescriber’s instructions and not adjust the dose on their own.
Is Morniflu safe in pregnancy or breastfeeding?+
Safety data for morniflumate during pregnancy and lactation are limited. As with most NSAIDs, it is generally advised to avoid use in the third trimester of pregnancy due to potential fetal complications, and caution is recommended while breastfeeding. The prescriber should evaluate risks versus benefits for each patient.
How do I order Morniflu from GNH USA?+
To request Morniflu, submit an enquiry on the product page at gnh-usa.com specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.
How does Morniflu compare with other NSAIDs?+
Morniflumate belongs to the same class of non‑steroidal anti‑inflammatory drugs as ibuprofen, diclofenac and naproxen, sharing a similar mechanism of COX inhibition. Compared with some NSAIDs, morniflumate may have a slightly different gastrointestinal tolerability profile, but overall efficacy and safety are comparable and must be assessed individually.
How should Morniflu be stored?+
Morniflu should be stored at ambient temperature, preferably below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and do not use it after the expiration date printed on the label.
How is Morniflu administered?+
Morniflu is supplied as an oral dosage form that should be taken with a full glass of water. It can be taken with or without food, although taking it with meals may reduce gastrointestinal discomfort. The exact dosing schedule is set by the prescribing clinician.
What are the most serious risks to watch for with Morniflu?+
The most serious adverse events associated with morniflumate include gastrointestinal ulceration or bleeding, severe allergic reactions such as anaphylaxis, hepatic injury, and renal impairment. Patients should be advised to seek immediate medical attention if they experience black stools, unexplained abdominal pain, jaundice, swelling, or signs of an allergic reaction.
Who should not use Morniflu?+
Morniflu is contraindicated in individuals with known hypersensitivity to morniflumate or other NSAIDs, those with active peptic ulcer disease, severe heart failure, or significant hepatic or renal impairment. It should also be avoided in patients who are in the third trimester of pregnancy. The prescribing clinician must evaluate each patient’s medical history before initiating therapy.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Morniflumate
Route
Oral Use
Manufacturer
Master Pharma S.R.L.
Origin
EU

Related products

Flomax

Flomax

Morniflumate

Chiesi Farmaceutici S.P.A.
EU
Flomax Adulti

Flomax Adulti

Morniflumate

Chiesi Farmaceutici S.P.A.
EU
Flomax Bambini

Flomax Bambini

Morniflumate

Chiesi Farmaceutici S.P.A.
EU
Flumarin

Flumarin

Morniflumate

I.B.N. Savio S.R.L.
EU